Impact of Residual Inducer on Titratable Expression Systems

por Afroz, Taliman, Luo, Michelle L., Beisel, Chase L.
Publicado 2015

Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn’s Disease...

por Dulai, Parambir S, Wan, Yaping, Huang, Zhongwen, Luo, Michelle
Publicado 2022

Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression

por Luo, Michelle L., Mullis, Adam S., Leenay, Ryan T., Beisel, Chase L.
Publicado 2015

Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients

por Khan, Nabeel, Vallarino, Carlos, Lissoos, Trevor, Darr, Umar, Luo, Michelle
Publicado 2017

Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis

por Revicki, Dennis A, Rentz, Anne M, Luo, Michelle P, Wong, Robert L
Publicado 2011

Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome

por Lacy, Brian, Ayyagari, Rajeev, Guerin, Annie, Lopez, Andrea, Shi, Sherry, Luo, Michelle
Publicado 2019

Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review

por Patel, Dipen, Martin, Stephan, Luo, Michelle, Ursos, Lyann, Lirio, Richard A, Kamble, Pravin, Wang, Song
Publicado 2022

Programmable Removal of Bacterial Strains by Use of Genome-Targeting CRISPR-Cas Systems

por Gomaa, Ahmed A., Klumpe, Heidi E., Luo, Michelle L., Selle, Kurt, Barrangou, Rodolphe, Beisel, Chase L.
Publicado 2014

Retraction: Psychometric characteristics of the ankylosing spondylitis quality of life questionnaire, short form 36 health survey, and functional assessment of chronic illness ther...

por Revicki, Dennis A, Rentz, Anne M, Luo, Michelle P, Wong, Robert L, Doward, Lynda C, McKenna, Stephen P
Publicado 2009

Psychometric characteristics of the ankylosing spondylitis quality of life questionnaire, short form 36 health survey, and functional assessment of chronic illness therapy-fatigue...

por Revicki, Dennis A, Rentz, Anne M, Luo, Michelle P, Wong, Robert L, Doward, Lynda C, McKenna, Stephen P
Publicado 2009

Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire

por Doward, Lynda C, McKenna, Stephen P, Meads, David M, Twiss, James, Revicki, Dennis, Wong, Robert L, Luo, Michelle P
Publicado 2007

The CRISPR RNA-guided surveillance complex in Escherichia coli accommodates extended RNA spacers

por Luo, Michelle L., Jackson, Ryan N., Denny, Steven R., Tokmina-Lukaszewska, Monika, Maksimchuk, Kenneth R., Lin, Wayne, Bothner, Brian, Wiedenheft, Blake, Beisel, Chase L.
Publicado 2016

Safety outcomes when switching between biosimilars and reference biologics: A systematic review and meta-analysis

por Herndon, Thomas M., Ausin, Cristina, Brahme, Nina N., Schrieber, Sarah J., Luo, Michelle, Andrada, Frances C., Kim, Carol, Sun, Wanjie, Zhou, Lingjie, Grosser, Stella, Yim, Sarah, Ricci, M. Stacey
Publicado 2023

Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes

por Koliani-Pace, Jenna L, Singh, Siddharth, Luo, Michelle, Hirten, Robert, Aniwan, Satimai, Kochhar, Gursimran, Chang, Shannon, Lukin, Dana, Gao, Youran, Bohm, Matthew, Swaminath, Arun, Gupta, Nitin, Shmidt, Eugenia, Meserve, Joseph, Winters, Adam, Chablaney, Shreya, Faleck, David M, Yang, Jiao, Huang, Zhongwen, Boland, Brigid S, Shashi, Preeti, Weiss, Aaron, Hudesman, David, Varma, Sashidhar, Fischer, Monika, Sultan, Keith, Shen, Bo, Kane, Sunanda, Loftus, Edward V, Sands, Bruce E, Colombel, Jean-Frederic, Sandborn, William J, Lasch, Karen, Siegel, Corey A, Dulai, Parambir S
Publicado 2019

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis

por Faleck, David M., Winters, Adam, Chablaney, Shreya, Shashi, Preeti, Meserve, Joseph, Weiss, Aaron, Aniwan, Satimai, Koliani-Pace, Jenna L., Kochhar, Gursimran, Boland, Brigid S., Singh, Siddharth, Hirten, Robert, Shmidt, Eugenia, Kesar, Varun, Lasch, Karen, Luo, Michelle, Bohm, Matthew, Varma, Sashidhar, Fischer, Monika, Hudesman, David, Chang, Shannon, Lukin, Dana, Sultan, Keith, Swaminath, Arun, Gupta, Nitin, Siegel, Corey A., Shen, Bo, Sandborn, William J., Kane, Sunanda, Loftus, Edward V., Sands, Bruce E., Colombel, Jean-Frederic, Dulai, Parambir S., Ungaro, Ryan
Publicado 2019

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

por Narula, Neeraj, Peerani, Farhad, Meserve, Joseph, Kochhar, Gursimran, Chaudrey, Khadija, Hartke, Justin, Chilukuri, Prianka, Koliani-Pace, Jenna, Winters, Adam, Katta, Leah, Shmidt, Eugenia, Hirten, Robert, Faleck, David, Parikh, Malav P., Whitehead, Diana, Boland, Brigid S., Singh, Siddharth, Sagi, Sashidhar Varma, Fischer, Monika, Chang, Shannon, Barocas, Morris, Luo, Michelle, Lasch, Karen, Bohm, Matthew, Lukin, Dana, Sultan, Keith, Swaminath, Arun, Hudesman, David, Gupta, Nitin, Shen, Bo, Kane, Sunanda, Loftus, Edward V., Siegel, Corey A., Sands, Bruce E., Colombel, Jean-Frederic, Sandborn, William J., Dulai, Parambir S.
Publicado 2019